Comparison of atypicals in first-episode psychosis (CAFE): A randomized, 52-week comparison of olanzapine, quetiapine, and risperidone

被引：0
|
作者：
McEvoy, JP [1 ]
Lieberman, JA [1 ]
Perkins, D [1 ]
Hamer, RM [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2005年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [21] Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach
    Koutsouleris, Nikolaos
    Kahn, Rene S.
    Chekroud, Adam M.
    Leucht, Stefan
    Falkai, Peter
    Wobrock, Thomas
    Derks, Eske M.
    Fleischhacker, Wolfgang W.
    Hasan, Alkomiet
    LANCET PSYCHIATRY, 2016, 3 (10): : 935 - 946
  • [22] Olanzapine versus risperidone in first-episode schizophrenic and schizoform disorders: A double-blind comparison
    Svestka, J
    Synek, O
    Zourkova, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S291 - S291
  • [23] Comparison of quetiapine ('Seroquel'), olanzapine, and risperidone in a randomized study in patients with schizophrenia
    Sacchetti, E
    Valseechi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S413 - S413
  • [24] Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year
    Benedicto Crespo-Facorro
    Victor Ortiz-Garcia de la Foz
    Ignacio Mata
    Rosa Ayesa-Arriola
    Paula Suarez-Pinilla
    Elsa M. Valdizan
    Obdulia Martinez-Garcia
    Rocío Pérez-Iglesias
    Psychopharmacology, 2014, 231 : 357 - 366
  • [25] Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year
    Crespo-Facorro, Benedicto
    Ortiz-Garcia de la Foz, Victor
    Mata, Ignacio
    Ayesa-Arriola, Rosa
    Suarez-Pinilla, Paula
    Valdizan, Elsa M.
    Martinez-Garcia, Obdulia
    Perez-Iglesias, Rocio
    PSYCHOPHARMACOLOGY, 2014, 231 (02) : 357 - 366
  • [26] An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes
    Cheng, Zhang
    Yuan, Yanbo
    Han, Xue
    Yang, Lei
    Cai, Shangli
    Yang, Fude
    Lu, Zheng
    Wang, Chuanyue
    Deng, Hong
    Zhao, Jingping
    Xiang, Yutao
    Correll, Christoph U.
    Yu, Xin
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (10) : 1227 - 1236
  • [27] Aripiprazole, Ziprasidone, and Quetiapine in the Treatment of First-Episode Nonaffective Psychosis Results of a 6-Week, Randomized, Flexible-Dose, Open-Label Comparison
    Crespo-Facorro, Benedicto
    Perez-Iglesias, Rocio
    Mata, Ignacio
    Ortiz-Garcia de la Foz, Victor
    Martinez-Garcia, Obdulia
    Valdizan, Elsa M.
    Vazquez-Barquero, Jose L.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (02) : 215 - 220
  • [28] A naturalistic comparison of atypical (olanzapine, risperidone) and conventional (haloperidol) in the acute treatment of patients with first episode of psychosis
    Perez, R
    Crespo-Facorro, B
    Martinez-Gonzalez, I
    Pelayo-Teran, JM
    Gonzalez-Blanch, C
    Ramirez-Bonilla, ML
    Vazquez-Barquero, JL
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 500 - 501
  • [29] Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone
    Rosa Ayesa-Arriola
    Jose Manuel Rodríguez-Sánchez
    Rocío Pérez-Iglesias
    Roberto Roiz-Santiáñez
    Obdulia Martínez-García
    Jose Sánchez-Moreno
    Rafael Tabarés-Seisdedos
    Jose L. Vázquez-Barquero
    Benedicto Crespo-Facorro
    Psychopharmacology, 2013, 227 : 615 - 625
  • [30] Randomized comparison of olanzapine versus risperidone for the treatment of first episode schizophrenia: Four month outcomes
    Robinson, DG
    Woerner, M
    Napolitano, B
    Patel, R
    Sevy, S
    Gunduz-Bruce, H
    Soto-Perello, J
    Mendelowitz, A
    Khadivi, A
    Miller, R
    McCormack, J
    Lorell, B
    Lesser, M
    Schooler, N
    Kane, J
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S250 - S250
12345